[In vitro activity of moxifloxacin (8-methoxyquinolone) alone or in combination with cefotaxime against group B streptococci]. [electronic resource]
- Pathologie-biologie Nov 2007
- 412-7 p. digital
Publication Type: Journal Article
0369-8114
10.1016/j.patbio.2007.07.004 doi
Anti-Bacterial Agents--therapeutic use Aza Compounds--therapeutic use Bacteremia--diagnosis Cefotaxime--therapeutic use Drug Therapy, Combination Fluoroquinolones Humans Infant, Newborn Meningitis, Bacterial--diagnosis Microbial Sensitivity Tests Moxifloxacin Quinolines--therapeutic use Serotyping Streptococcal Infections--diagnosis Streptococcus agalactiae--classification